Jana G Hashash, MD, MSc

@JHashashMD

Assoc Prof of Med, GI with IBD focus @MayoClinic 🐊 | via @AUB_Lebanon @PittGIM @PittGILiverNutr | Chair of @AmerGastroAssn CPUC | ❤️ Research to 📈👫 Outcome

Florida, USA

Joined March 2019

528Following

2KFollowers

Jana G Hashash, MD, MSc Retweeted

Saqr Alsakarneh, MD, MSc@AlsakarnehSaqr · 7 h

Happy to see our work published @APandT ‼️ ✅Isolated #PSC - even without #IBD - is an independent risk factor for #CRC! Hope it sparks further research and screening guidelines 🙏🏻 📖: onlinelibrary.wiley.com/doi/10.1111/ap… Grateful to continue working with the genius team @AasmaShaukatMD…

2.0K

Jana G Hashash, MD, MSc@JHashashMD · Jul 19

Check out practical advice 📝 on Monitoring Inflammatory Bowel Disease Activity: When, How, and Why In @AmCollegeGastro @AmJGastro with @JillGaidosMD ✅ for: 🚽🩸Clinical response and remission 🧪💩💉Biochemical 🧐🔎🔬Endoscopic 🩻 Radiographic pubmed.ncbi.nlm.nih.gov/40488637/

JHashashMD's tweet image. Check out practical advice 📝 on

Monitoring Inflammatory Bowel Disease Activity: When, How, and Why

In @AmCollegeGastro @AmJGastro with @JillGaidosMD

✅ for:

🚽🩸Clinical response and remission
🧪💩💉Biochemical
🧐🔎🔬Endoscopic
🩻 Radiographic

pubmed.ncbi.nlm.nih.gov/40488637/

5.0K

Jana G Hashash, MD, MSc Retweeted

Mariam Naveed, MD@MN_GIMD · Jul 14

Just one month to go until @AdventHealthCFL Updates in GI & Hepatology! ✅ Incredible speakers 🏝️ Stunning venue @TheAlfondInn 📍 Details & registration ⬇️ web.cvent.com/event/973bfc36… #AHUpdates2025 #GITwitter

4.0K

Jana G Hashash, MD, MSc Retweeted

Passisd Laoveeravat@passisd · Jul 14

While starting the first week of advanced IBD fellowship @MayoClinicFLGIH, Excited to share that our work has been accepted for the presentation at ACG 2025! @tarek_odahMD @JHashashMD @FarrayeIBD See you in Phoenix!

2.0K

Jana G Hashash, MD, MSc@JHashashMD · Jul 12

‼️Can’t wait for @AmCollegeGastro 2025 to reconnect with friends 👩‍🔬👨‍🔬 from all over the 🌍 and showcase the exciting 📝 our research team, residents, and fellows have been working on! Especially excited to present our experience on #autoloStemCellTransplants for #CrohnsDisease

JHashashMD's tweet image. ‼️Can’t wait for @AmCollegeGastro 2025 to reconnect with friends 👩‍🔬👨‍🔬 from all over the 🌍 and showcase the exciting 📝 our research team, residents, and fellows have been working on!

Especially excited to present our experience on #autoloStemCellTransplants for #CrohnsDisease

3.0K

Jana G Hashash, MD, MSc Retweeted

IBDJournal & CC360@IBDJournals · Jul 2

Does Metformin affect outcomes in pts with IBD and type 2 DM? 💊🧐 ✅ Possibly! According to a population based study with >2500 pts and 3 years follow up showing: ⬇️ Use of steroids ⬇️ risk of ✂️ in CD @JessPetrovMD @GKochharMD @ibdgijami @JHashashMD doi.org/10.1093/ibd/iz…

2.0K

Jana G Hashash, MD, MSc Retweeted

Tauseef Ali MD, FACG AGAF FACP@ibdtweets · Jun 30

With pouchitis (58% at 1 year) and Crohn 's-like disease (10.3% at 10 years) common after IPAA for ulcerative colitis, and risk factors like 🚬nicotine dependence, and💉 prior biologic use increasing pouchitis risk, plus obesity linked to higher advanced therapy use. Should we…

2.0K

Jana G Hashash, MD, MSc Retweeted

ACG_CTG@ACG_CTG · Jun 30

Patients With IBD Are at Increased Risk of RSV Infections After SARS-CoV-2 Infection: A Propensity-Matched Cohort Analysis @AlsakarnehSaqr & @OscarRamirezMD, et al. ➡️ bit.ly/4eej4oY @JHashashMD @FarrayeIBD @dr_fcalderaibd

2.0K

Jana G Hashash, MD, MSc Retweeted

Mario El Hayek@mario_elhayek · Jun 28

🚨Pub Alert - RT in IBD patients with Abdomen/Pelvic Ca | @DDS_Journal 📊 SR | 21 Studies | 1,226 patients 💥 IBD flares in 3.5–15% within 6m, rectal IBD & chemo+RT 📈risk 💩 Toxicities: diarrhea, proctitis, rectal bleeding ⚠️ Acute & late GI grade III-IV tox up to 23% & 15%

1.0K

Jana G Hashash, MD, MSc Retweeted

Saqr Alsakarneh, MD, MSc@AlsakarnehSaqr · Jun 18

New Publication 🚨 in @IBDJournals In this real world data we show that patients with Crohn’s disease who underwent Terminal Ileum (TI) resection are at increased risk of CRC: 📌CD with TI resection vs without resection (aHR: 2.58 , p<0.01) 📌CD with TI resection and disease…

4.0K

Jana G Hashash, MD, MSc Retweeted

Antonio Caballero Mateos PhD@Dr_ACaballero_ · Jun 9

🧵AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With IBD: Expert Review 🍎Let’s break down the key recommendations for patients & clinicians A thread👇 @AGA_CGH @JHashashMD @MayoClinicGIHep @virginut #IBD #MedTwitter #Nutrition #MedEd #GITwitter

128

106

15.0K

Jana G Hashash, MD, MSc Retweeted

IBDJournal & CC360@IBDJournals · Jun 5

👄Oral EIMs -mostly aphthous ulcers- are common in IBD and can be the presenting symptom ✅ Nearly half of the oral findings in this study were attributed to IBD and 40% occurred with an IBD flare 🔥 doi.org/10.1093/crocol…

3.0K

Jana G Hashash, MD, MSc Retweeted

Katie Dunleavy@dunleavy_katie · Jun 2

1/#MondayNightIBD #Back2Basics 🎯#dysplasia surveillance in #IBD ✅Incidence ✅Risk factors ✅Surveillance guidelines: when, how often ✅Surveillance in IPAA ✅CLN modalities ✅Dysplasia classification ✅Random vs 🎯'd biopsies ✅Mgmt of dysplasia @ibd_MB @britsocgastro @SDolwani

4.0K

Jana G Hashash, MD, MSc Retweeted

Jami Kinnucan, MD, FACG, AGAF, FCCF@ibdgijami · Jun 2

Celebrating @MayoClinicFLGIH 3rd #IBD fellow Dr. Inas Mikhail Abu-Dhabi UAE last July and has been able to learn #IUS @iUSCAN and so much more! Proud to see her go expand #IBD and #IUS in New York!

2.0K

Jana G Hashash, MD, MSc Retweeted

Bincy Abraham, MD, MS@IBD_Houston · May 31

@JHashashMD deciphers GLP1s for GIs: individualize when to d/c prior to endoscopy based on other factors i e. diabetes.. Interestingly, are we treating ourselves? GLP effects last >5 to 6 weeks!!! GLPs benefits in IBD pts and reduces colon cancer risk!

4.0K

Jana G Hashash, MD, MSc@JHashashMD · Jun 1

And I got to do my first #IUS under the direct supervision of the one and only @IBD_Houston!!

BBincy Abraham, MD, MS@IBD_Houston · May 31

3.0K

Jana G Hashash, MD, MSc@JHashashMD · May 31

Thrilled to share the stage with @IBD_Houston @BrennanSpiegel @jajook01 @JHashashMD and Brooks Cash! Thank you for a great panel discussion and conference! @PrasunJalal @HMethodistMD @BrighamGI @MethodistHosp @CedarsSinai @UtGastro @bcmhouston @MayoClinic

EEamonn Quigley@eamonnquigleymd · May 31

Great session at Texas GI and hepatology roundup. GLP-1 agonists, Bariatric endoscopy, CRC disease, pancreatitis and A-I chaired by @IBD_Houston.

2.0K

Jana G Hashash, MD, MSc Retweeted

Bincy Abraham, MD, MS@IBD_Houston · May 31

@eamonnquigleymd updates us on IBS, upcoming ROME V guidelines, management of bloating, "live biotherapeutic products" aka probiotics ex's, as well as FMT and super donors in treating IBS.

705

Jana G Hashash, MD, MSc Retweeted

Eamonn Quigley@eamonnquigleymd · May 31

Great session at Texas GI and hepatology roundup. GLP-1 agonists, Bariatric endoscopy, CRC disease, pancreatitis and A-I chaired by @IBD_Houston.

2.0K

Jana G Hashash, MD, MSc Retweeted

Bincy Abraham, MD, MS@IBD_Houston · May 28

Looking forward to seeing everyone this Saturday at our GI and Hepatology Roundup conference, Texas style! If you haven't registered, scan below. We have an amazing group of renowned faculty! @bcmhouston @HMethodistMD @eamonnquigleymd @UtGastro @MayoClinic @ThomasRMcCarty3

2.0K